|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00690 UNI-BIO GROUP
Nominal 
0.131 +0.001 (+0.769%) | 2024/12 - Final HKD(K$) | %Chg (Compare to Final) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | |
| Turnover | 552,980 | 14.083% | 484,718 | 440,316 | 353,405 | 208,776 |
| Cost of Sales | (91,912) | 0.013% | (91,900) | (105,433) | (76,398) | (27,682) |
| Gross Profit | 461,068 | 17.374% | 392,818 | 334,883 | 277,007 | 181,094 |
| 2024/12 - Final HKD(K$) | %Chg (Compare to Final) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | (2,307) | (15,610) | -- | |
| Share of Results of Asso. & JCEs | (1) | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 91,170 | 20.119% | 75,900 | 43,287 | (20,012) | (70,941) | |
| Taxation | (8,396) | 67.118% | (5,024) | (4,775) | 421 | (378) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 82,774 | 16.787% | 70,876 | 38,512 | (19,591) | (71,319) | |
| 2024/12 - Final HKD(K$) | %Chg (Compare to Final) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | |
| Net Finance Costs / (Income) | (2,162) | 281.305% | (567) | (921) | 6 | (425) |
| Depreciation & Amortisation | 21,350 | 26.466% | 16,882 | 17,546 | 20,850 | 20,920 |
| Directors' Emoluments | 5,500 | 68.763% | 3,259 | 3,081 | 4,540 | 8,291 |
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| EPS (cts) | 1.350 | 21.622% | 1.110 | 0.610 | -0.310 | -1.110 |
| DPS (cts) | 0.277 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | 20.519% | -- | -- | -- | -- | -- |
| Cash flow per share ($) | 0.011 | -- | 0.016 | 0.008 | 0.002 | (0.002) |
| NBV per share ($) | 0.055 | -- | 0.040 | 0.031 | 0.027 | 0.030 |
| Remarks: | Real time quote last updated: 28/10/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD 75,955 |
| %Change | 12.723% |
| EPS / (LPS) | HKD 0.013 |
| NBV Per Share ($) | HKD 0.064 |